Recombinant Human NDUFA1 Protein，GST

NDUFA1, or NADH-ubiquinone oxidoreductase subunit A1, is a crucial component of the mitochondrial respiratory chain, specifically part of Complex I. This enzyme plays a pivotal role in cellular energy production by facilitating the transfer of electrons from NADH to ubiquinone, ultimately contributing to ATP synthesis through oxidative phosphorylation. Mutations in the NDUFA1 gene have been linked to various mitochondrial diseases, leading to a spectrum of clinical manifestations ranging from psychomotor retardation to cardiomyopathy. Due to its essential role in mitochondrial function and energy metabolism, NDUFA1 has garnered significant research interest, particularly in the context of developing therapeutic strategies for mitochondrial disorders. Recombinant protein studies of NDUFA1 allow for enhanced understanding of its biochemical properties, functional mechanisms, and interactions within the respiratory chain. These studies may also aid in the elucidation of the pathogenic mechanisms associated with NDUFA1-related diseases. By generating and characterizing NDUFA1 recombinant proteins, researchers can explore the structure-function relationship of this subunit and its influence on Complex I activity. Furthermore, these investigations may lead to potential biotechnological applications, such as developing enzyme replacement therapies or small molecule compounds aimed at restoring or enhancing the function of NDUFA1 in affected individuals. Overall, research on NDUFA1 recombinant proteins is vital for advancing our understanding of mitochondrial dysfunction and developing novel interventions for the treatment of related health conditions.